Changes in Psychotropic Drug Blood Levels After SARS-CoV-2 Vaccination: A Two-Center Cohort Study.

Maxim KuzinFabian GardinMarkus GötschiFranziskos XepapadakosWolfram KawohlErich SeifritzAntje TrauzeddelMichael PaulzenGeorgios Schoretsanitis

Published in: Therapeutic drug monitoring (2023)

This study provides the first evidence of major changes in the plasma levels of escitalopram, fluoxetine, trazodone, and quetiapine after COVID-19 vaccination. When planning COVID-19 vaccination for patients treated with these medications, clinicians should monitor rapid changes in bioavailability and consider short-term dose adjustments to ensure safety.

Keyphrases

sars cov
coronavirus disease
respiratory syndrome coronavirus
major depressive disorder
emergency department
loop mediated isothermal amplification